Led by Sophie Cain Miller, M.D., M.P.H., Mohammad H. Dar, M.D., Maria E. Finnell, M.D., Douglas G. Fish, M.D., Christopher R. Cogle, M.D., Medicaid Medical Directors in Washington, Massachusetts, Indiana, New York, and Florida examine how cell and gene therapies can be effectively integrated into Medicaid programs, focusing on their potential and the challenges involved in a JAMA Pediatrics publication titled Medicaid and the Promise for Cure. The authors, consisting of members of AcademyHealth’s Medicaid Medical Directors Network, provide a framework to assess cell and gene therapies and evaluate payment options, ensuring equitable access. The article includes information on:
- Assessing cell and gene therapies
- Evaluating payment options
- Policy recommendations based on safety, effectiveness, population health, access, and budget
Read the full article here. Please note that a JAMA subscription is required.